RA CAPITAL MANAGEMENT L.P. 13D/13G Filings for TG Therapeutics, Inc. (TGTX)

RA CAPITAL MANAGEMENT L.P. 13D and 13G filings for TG Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2021-02-10
4:49 pm
Sale		2021-01-3113GTG Therapeutics, Inc.
TGTX		RA CAPITAL MANAGEMENT L.P.6,361,123
4.700%		-6,427,334decrease
(-50.26%)		Filing
2020-06-10
4:15 pm
Purchase		2020-05-3113GTG Therapeutics, Inc.
TGTX		RA CAPITAL MANAGEMENT L.P.12,788,457
10.800%		2,908,134increase
(+29.43%)		Filing